Metastatic Hormone Sensitive Prostate Cancer

Explore clinical trials studying Metastatic Hormone Sensitive Prostate Cancer. Study availability and eligibility vary by location and protocol.

5 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Hormone Sensitive Prostate Cancer trial results

Recruiting

NCT07005154

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: Clearview Cancer Institute Huntsville, Alabama, United States

Sharp HealthCare - Sharp Memorial Hospital San Diego, California, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

Associated Urological Specialists Chicago Ridge, Illinois, United States

View all 50 locations

Recruiting

NCT05720130

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: Royal Brisbane & Women's Hospital Brisbane, Queensland, Australia

Princess Alexandra Hospital Brisbane, Queensland, Australia

Gold Coast University Hospital Southport, Queensland, Australia

Recruiting

NCT07339267

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: Beijing Hospital Beijing, Beijing Municipality, China

Completed

NCT02677896

Conditions: Metastatic Hormone Sensitive Prostate Cancer
Locations: Site US10016 Homewood, Alabama, United States

Site US10007 Anchorage, Alaska, United States

Site US10008 Tucson, Arizona, United States

Site US10034 Fountain Valley, California, United States

View all 203 locations

Active, Not Recruiting

NCT04076059

Conditions: Metastatic Hormone Sensitive Prostate Cancer
Locations: Site CN86022 Beijing, China

Site CN86035 Beijing, China

Site CN86024 Changchun, China

Site CN86009 Changsha, China

View all 28 locations